Home The Active Ingredient Matrix N-Acetyl-Carnosine

Formulation Intelligence

N-Acetyl-Carnosine

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for N-Acetyl-Carnosine.

N-Acetyl-Carnosine is a dipeptide derivative that functions as a prodrug to L-carnosine, specifically engineered for enhanced resistance to carnosinase degradation to provide sustained antioxidant protection against oxidative stress-induced protein glycation and lipid peroxidation in ocular and systemic tissues.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

119058

Molecular Weight

318.4 g/mol

XLogP3 (Lipophilicity)

4.6

IUPAC Name

2-(3,7-dimethylocta-2,6-dienyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

  • Lutein for synergistic protection against blue-light induced macular oxidative stress
  • Vitamin E for enhanced inhibition of lipid peroxidation within cellular membranes

Biological Formulation Enhancers

  • Hydroxypropyl-beta-cyclodextrin for improved aqueous solubility and stabilization against premature hydrolysis
  • Chitosan for increased mucoadhesive residence time in ophthalmic or mucosal delivery applications

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for N-Acetyl-Carnosine across standard consumer modalities.

💊 Standard Capsules

The primary formulation constraint is its hygroscopic nature, which requires moisture-barrier packaging to prevent hydrolytic degradation into L-carnosine and acetic acid within the capsule shell.

🍬 Gummy & Pectin Formats

High processing temperatures during the pectin gelation phase can accelerate the deacetylation of the molecule, potentially altering its pharmacokinetic profile and reducing its resistance to carnosinase.

🔬 Thin-Film Oral Strips

The relatively high therapeutic dosage requirements for systemic efficacy often exceed the 50mg payload capacity of standard thin-film polymer matrices, necessitating high-potency micronization or complexation.

For Brand Founders

Formulate with N-Acetyl-Carnosine

Ready to launch a product featuring N-Acetyl-Carnosine? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize N-Acetyl-Carnosine Bioavailability

Need absolute proof that your N-Acetyl-Carnosine extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

N-Acetyl-Carnosine Degradation Testing

Is your N-Acetyl-Carnosine payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation